Zhitong Financial App News, EPS Chuangjian Technology (03860) announced that for the six months ended September 30, 2021, income was HK $246 million, up 19.1% from the same period last year; gross profit was HK $30.6 million, up 14% from the same period last year; loss attributable to shareholders was HK $5.425 million, compared with a profit of HK $4.471 million or HK1.1 cents per share in the same period last year.
During the reporting period, the increase in the Group's gross profit was mainly due to a major customer headquartered in the United States; the Group's loss was mainly due to the research costs of the new drug development project of approximately HK $5.4 million; the professional fee for an unconditional mandatory cash offer as a result of the change of corporate control disclosed in the company's announcement on May 5, 2021 was approximately HK $1.4 million.